BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22954187)

  • 1. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations.
    Jadvar H; Yap LP; Park R; Li Z; Chen K; Hughes L; Kouhi A; Conti P
    Mol Imaging; 2012; 11(5):426-32. PubMed ID: 22954187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Androgen on Normal Biodistribution of [
    Jadvar H; Park R; Yap LP; Chen K; Hughes L; Conti P
    Anticancer Res; 2017 Feb; 37(2):475-479. PubMed ID: 28179292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
    Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
    J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
    Nishii R; Volgin AY; Mawlawi O; Mukhopadhyay U; Pal A; Bornmann W; Gelovani JG; Alauddin MM
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):990-8. PubMed ID: 18057932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
    Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
    Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.
    Buursma AR; Rutgers V; Hospers GA; Mulder NH; Vaalburg W; de Vries EF
    Nucl Med Commun; 2006 Jan; 27(1):25-30. PubMed ID: 16340720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model.
    Alauddin MM; Shahinian A; Gordon EM; Conti PS
    Mol Imaging; 2004 Apr; 3(2):76-84. PubMed ID: 15296672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
    Bading JR; Shahinian AH; Vail A; Bathija P; Koszalka GW; Koda RT; Alauddin MM; Fissekis JD; Conti PS
    Nucl Med Biol; 2004 May; 31(4):407-18. PubMed ID: 15093810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
    Oyama N; Ponde DE; Dence C; Kim J; Tai YC; Welch MJ
    J Nucl Med; 2004 Mar; 45(3):519-25. PubMed ID: 15001697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring tumor response with [18F]FMAU in a sarcoma-bearing mouse model after liposomal vinorelbine treatment.
    Chan PC; Wu CY; Chang WT; Lin CY; Tseng YL; Liu RS; Alauddin MM; Lin WJ; Wang HE
    Nucl Med Biol; 2013 Nov; 40(8):1035-42. PubMed ID: 23969084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Journey of 2'-deoxy-2'-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU): from Antiviral Drug to PET Imaging Agent.
    Alauddin MM
    Curr Med Chem; 2018; 25(16):1867-1878. PubMed ID: 29189119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
    Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
    J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer.
    Varghese B; Velez E; Desai B; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e245-e246. PubMed ID: 29742600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
    Sun H; Sloan A; Mangner TJ; Vaishampayan U; Muzik O; Collins JM; Douglas K; Shields AF
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):15-22. PubMed ID: 15586282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression.
    Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
    J Nucl Med; 2004 Dec; 45(12):2063-9. PubMed ID: 15585483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosynthesis of 2'-deoxy-2'-[18F]-fluoro-5-methyl-1-beta-L-arabinofuranosyluracil ([18F]-L-FMAU) for PET.
    Mukhopadhyay U; Pal A; Gelovani JG; Bornmann W; Alauddin MM
    Appl Radiat Isot; 2007 Aug; 65(8):941-6. PubMed ID: 17517516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
    Tehrani OS; Muzik O; Heilbrun LK; Douglas KA; Lawhorn-Crews JM; Sun H; Mangner TJ; Shields AF
    J Nucl Med; 2007 Sep; 48(9):1436-41. PubMed ID: 17785728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression.
    Alauddin MM; Shahinian A; Park R; Tohme M; Fissekis JD; Conti PS
    Nucl Med Biol; 2004 May; 31(4):399-405. PubMed ID: 15093809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
    Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
    Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.